DS Research

Dermatology Specialists Research

  • Home
  • Who We Are
    • About
    • Meet Nina M. Scott
    • Meet Our Doctors
    • Meet Our Staff
  • Facilities
    • Kentucky Facility
    • Indiana Facility
    • Travel Accommodations
  • Research Studies
    • Enrolling Studies
  • Sponsor/CRO
  • News
  • Contact

Mirvaso works for Lupus, Dermatomyositis and Pityriasis Rubra Pilaris

April 4, 2016 by admin Leave a Comment

The off label use for Mirvaso gel is becoming better documented with the publication of a recent paper suggesting that Mirvaso was well tolerated by and offered good benefits to sufferers of Systemic Lupus, Dermatomyositis and Pityriasis Rubra Pilaris. These conditions share a symptom – erythema, that is the appearance of a red face. Only 3 patients… Read More

Research Does Not End at Medicines Approval

March 22, 2016 by admin Leave a Comment

Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA).  In fact, that’s when post-approval research and monitoring begin and they help all health care stakeholders, including physicians and patients, to better understand the full value of… Read More

7 FUNDAMENTAL QUESTIONS TO ASK ABOUT CLINICAL TRIALS

March 17, 2016 by admin Leave a Comment

No matter if clinical trials are sponsored by the industry or government, they have the goal to improve or discover completely new ways for treating diseases. But most of all, researches are capable of dictating the advancement of medicine and healthcare. There are millions of volunteers who realize how important for the sector and humans… Read More

Eli Lilly’s Ixekizumab Positive in Plaque Psoriasis Studies

March 14, 2016 by admin Leave a Comment

Eli Lilly and Company LLY announced encouraging results from two phase III studies, UNCOVER-2 and UNCOVER-3, on ixekizumab for the treatment of patients with moderate-to-severe plaque psoriasis. This double-blind, multicenter, phase III studies evaluated ixekizumab, in comparison to Amgen Inc.’s AMGN Enbrel (etanercept) or placebo, in patients with moderate-to-severe plaque psoriasis. In both the studies,… Read More

SDEF: Have higher degree of suspicion for pediatric allergic contact dermatitis

March 4, 2016 by admin Leave a Comment

Allergic contact dermatitis is often missed in pediatric patients who present with eczema-like skin eruptions, in part because less is known about ACD in children than in adults. “Often when we see a child with dermatitis, we automatically think of atopic dermatitis, but we should also consider the possibility of allergic contact dermatitis,” Dr. Joseph… Read More

New Location and Local Research Partnership

February 25, 2016 by admin Leave a Comment

We have opened up a new office in New Albany, Indiana . Our Location is at 2241 Green Valley Road, New Albany, IN 47150 . Below we have pictures of our new office and staff.  We have also partnered with another local dermatology specialist  “Associates in Dermatology ” for the purpose of studying  psoriasis, acne, and rosacea.

US FDA Nod for Psoriasis Spray by Dr Reddy’s

February 15, 2016 by admin Leave a Comment

A US subsidiary of Dr Reddy’s laboratory, Promius Pharma, has been successful in getting US FDA approval for its psoriasis spray. This prescription spray, called Sernivo, contains 0.05% betamethasone dipropionate and can be used for external application for psoriasis among patients who are 18 years or over. “As an emerging leader in the dermatology space,… Read More

Novartis Gets FDA Nod for Label Expansion of Cosentyx

February 1, 2016 by admin Leave a Comment

By Zacks Equity Research  AG NVS announced that the FDA has approved its arthritis drug, Cosentyx (secukinumab), in two new indications – for the treatment of adults with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA). The approvals came on the back of positive efficacy and safety outcomes from four placebo-controlled phase III studies.… Read More

Anacor Pharmaceuticals Submits New Drug Application to the FDA for Crisaborole Topical Ointment, 2% for the Treatment of Mild-to-Moderate Atopic Dermatiti

January 13, 2016 by admin Leave a Comment

PALO ALTO, Calif.–(BUSINESS WIRE)–Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of crisaborole topical ointment, 2%, a novel non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis in children and adults.… Read More

Knowing When To See A Dermatologist

August 5, 2015 by admin Leave a Comment

Our skin is the largest organ of our body, making skincare a multi-billion dollar industry.  Shelves are stocked full of products for the treatment and papering of our skin.  Creams and oils claiming to turn back the clock and remove wrinkles, ointments for warts, Eczema, or other conditions, and more lotions than you can imagine… Read More

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6

Contact Us

DS Research – Kentucky Location
3810 Springhurst Blvd.
Suite 130
Louisville, KY 40241
O: 502.585.9059
F: 502.585.9708

DS Research – Indiana Location
1005 E. Lewis & Clark Pkwy
Clarksville, IN 47129
O: 502.373.2849
F: 502.373.2872

Interested About Coming To Us? Our doctors are ready to see you now.

  • This field is for validation purposes and should be left unchanged.

dsrtrials

Are you struggling with #eczema? Call us today to Are you struggling with #eczema? Call us today to find out how we can help!
New Enrolling Studies⭐️⭐️⭐️ Give us a New Enrolling Studies⭐️⭐️⭐️ Give us a call today for more information on how we can help you achieve clear skin💚
.
.
.
.
.
.
#dsresearch #dermatology #kentucky #indiana #skin #eczema #psoriasis #alopecia #allergies #research #clinicaltrials
We had a sweet little Valentine visit us today❤️🪴🌹
Tonight we said farewell to one of our amazing coo Tonight we said farewell to one of our amazing coordinators as she starts a heavy semester as a nurse practitioner student. We are so happy and excited for her and very glad we were all able to get together one last time. Thank you Megan for all you have done! We will miss you.
Load More... Follow on Instagram

Copyright © 2023 DS Research :: Dermatology Specialists Research

  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Twitter